| 1 |
18302761 | NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols. | 2008 Feb 26 |
1 |
| 2 |
17760507 | Nitroaspirin (NCX-4016), an NO donor, is antiangiogenic through induction of loss of redox-dependent viability and cytoskeletal reorganization in endothelial cells. | 2007 Nov |
1 |
| 3 |
16144976 | Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016). | 2005 Dec |
1 |
| 4 |
15063462 | Chemiluminescence and LC-MS/MS analyses for the study of nitric oxide release and distribution following oral administration of nitroaspirin (NCX 4016) in healthy volunteers. | 2004 Apr 16 |
1 |
| 5 |
12207011 | NCX-4016, a nitric oxide-releasing aspirin, protects endothelial cells against apoptosis by modulating mitochondrial function. | 2002 Oct |
1 |